| Term
or Phrase |
 |
English
Translation |
|
|
|
| Acquisition
strategy |
|
The
current products have no market |
|
|
|
| Basically
on plan |
|
Revenue
shortfall of 25 percent |
|
|
|
| Bio-tech
business model |
|
Potentially
bigger fools have been identified |
|
|
|
| Considerably
ahead of plan |
|
Hit
plan in one of last three months |
|
|
|
| Core
business |
|
Obsolete
product line |
|
|
|
| Currently
revising the budget |
|
Financial
plan is in total chaos |
|
|
|
| Cyclical
industry |
|
Posted
a huge loss last year |
|
|
|
| Entrepreneurial
CEO |
|
Totally
uncontrollable, bordering on maniacal |
|
|
|
| Ingredients
are there |
|
Given
two years, we might find a workable strategy |
|
|
|
| Investing
heavily in R&D |
|
Trying
desperately to catch the competition |
|
|
|
| Limited
downside |
|
It
can’t get much worse |
|
|
|
| Long
selling cycle |
|
Yet
to find a customer who likes the product |
|
|
|
| Major
opportunity |
|
Last
chance |
|
|
|
| Niche
strategy |
|
A
small-time player |
|
|
|
| On
a manufacturing learning curve |
|
Can’t
make the product with positive margins |
|
|
|
| Possibility
of a slight shortfall |
|
A
revenue shortfall of 50 percent |
|
|
|
| Repositioning
the business |
|
Multimillion-dollar
investment recently written off |
|
|
|
| Somewhat
below the plan |
|
Revenue
shortfall of 75 percent |
|
|
|
| Strategic
investor |
|
Investor
who will pay a preposterous valuation |
|
|
|
| Too
early to tell |
|
Results
to date have been grim |
|
|
|
| Turnaround
opportunity |
|
Lost
cause |
|
|
|
| Unique |
|
No
more than six competitors |
|
|
|
| Upgrading
the management team |
|
The
organization is in complete disarray |
|
|
|
| Volume
sensitive |
|
Massive
fixed costs |
|
|
|
| Well
below plan |
|
An
outright, unmitigated disaster |
|
|
|
| Window
of opportunity |
|
Without
more money, the company is dead |
|
|
|
| Work
closely with management |
|
Talk
to them on the phone once a month |
